Systemic artery-to-pulmonary artery fistulas and recurrence of noncancer-related hemoptysis after bronchial artery embolization: a retrospective study

To investigate the clinical and angiographic characteristics of systemic artery-to-pulmonary artery fistulas (SA-PAFs) in patients with noncancer-related hemoptysis undergoing bronchial artery embolization (BAE), and to assess their associations with procedural outcomes and recurrent hemoptysis. We retrospectively analyzed consecutive patients with noncancer-related hemoptysis treated with BAE between January 2020 and December 2024. Patients were categorized as having non-SA-PAF, mild SA-PAF, or massive SA-PAF on angiography. Clinical features, angiographic findings, embolization outcomes, and recurrence-free survival were compared. Cox regression analyses were used to identify factors associated with recurrence. Among 276 included patients, SA-PAFs were identified in 216 (78.3%), including 134 (48.6%) with mild SA-PAF and 82 (29.7%) with massive SA-PAF. Massive SA-PAF was associated with greater vascular complexity, including more culprit arteries and more frequent ectopic bronchial artery and non-bronchial systemic artery involvement. The overall clinical success rate was 98.2%, but complete cessation of hemoptysis was less frequent in the massive SA-PAF group (79.3%) than in the mild SA-PAF (91.0%) and non-SA-PAF (95.0%) groups. Among 271 patients with clinical success and follow-up, recurrence occurred in 54 (19.9%) and was most frequent in the massive SA-PAF group (32.9%). Recurrence-free survival was significantly worse in patients with massive SA-PAF. In the primary multivariable model, TB-related disease was independently associated with recurrence, whereas SA-PAF classification was not. In exploratory models, ectopic bronchial artery was independently associated with recurrence. SA-PAFs are common angiographic findings in noncancer-related hemoptysis treated with BAE. Massive SA-PAF is associated with greater vascular complexity and poorer unadjusted outcomes, whereas TB-related disease remained the most robust independent predictor of recurrence and ectopic bronchial artery may represent an additional exploratory angiographic marker.

Authors

Institutions

Publication Details

Journal
BMC Pulmonary Medicine
Published
2026-09-24
DOI
https://doi.org/10.1186/s12890-026-04731-z
Primary Topic
Vascular Anomalies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Systemic artery-to-pulmonary artery fistulas and recurrence of noncancer-related hemoptysis after bronchial artery embolization: a retrospective study

Yuxia Cui, Wang Jing-zhong, Yongjuan Wu, Sen Jiang et al.
BMC Pulmonary Medicine
Vascular Anomalies and Treatments
article

Systemic artery-to-pulmonary artery fistulas and recurrence of noncancer-related hemoptysis after bronchial artery embolization: a retrospective study

Yuxia Cui, Wang Jing-zhong, Yongjuan Wu, Sen Jiang, Guohua Cheng, An Li, Zhu-ting Fang, Xiao-Qi Li, Jun Han, Yu-Lan Zheng, E. Guo, Xue-Jiao Yang
article en

Abstract

To investigate the clinical and angiographic characteristics of systemic artery-to-pulmonary artery fistulas (SA-PAFs) in patients with noncancer-related hemoptysis undergoing bronchial artery embolization (BAE), and to assess their associations with procedural outcomes and recurrent hemoptysis. We retrospectively analyzed consecutive patients with noncancer-related hemoptysis treated with BAE between January 2020 and December 2024. Patients were categorized as having non-SA-PAF, mild SA-PAF, or massive SA-PAF on angiography. Clinical features, angiographic findings, embolization outcomes, and recurrence-free survival were compared. Cox regression analyses were used to identify factors associated with recurrence. Among 276 included patients, SA-PAFs were identified in 216 (78.3%), including 134 (48.6%) with mild SA-PAF and 82 (29.7%) with massive SA-PAF. Massive SA-PAF was associated with greater vascular complexity, including more culprit arteries and more frequent ectopic bronchial artery and non-bronchial systemic artery involvement. The overall clinical success rate was 98.2%, but complete cessation of hemoptysis was less frequent in the massive SA-PAF group (79.3%) than in the mild SA-PAF (91.0%) and non-SA-PAF (95.0%) groups. Among 271 patients with clinical success and follow-up, recurrence occurred in 54 (19.9%) and was most frequent in the massive SA-PAF group (32.9%). Recurrence-free survival was significantly worse in patients with massive SA-PAF. In the primary multivariable model, TB-related disease was independently associated with recurrence, whereas SA-PAF classification was not. In exploratory models, ectopic bronchial artery was independently associated with recurrence. SA-PAFs are common angiographic findings in noncancer-related hemoptysis treated with BAE. Massive SA-PAF is associated with greater vascular complexity and poorer unadjusted outcomes, whereas TB-related disease remained the most robust independent predictor of recurrence and ectopic bronchial artery may represent an additional exploratory angiographic marker.

BMC Pulmonary Medicine
Tongji University (CN), Fujian Medical University (CN), Hubei University of Arts and Science (CN), Shanghai Pulmonary Hospital (CN), Fujian Provincial Hospital (CN), Fujian Provincial Cancer Hospital (CN)
Good health and well-being
Openalex Percentile: Top 12%
Vascular Anomalies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.